azacrin has been researched along with cgp 60474 in 1 studies
Studies (azacrin) | Trials (azacrin) | Recent Studies (post-2010) (azacrin) | Studies (cgp 60474) | Trials (cgp 60474) | Recent Studies (post-2010) (cgp 60474) |
---|---|---|---|---|---|
6 | 0 | 0 | 19 | 0 | 10 |
Protein | Taxonomy | azacrin (IC50) | cgp 60474 (IC50) |
---|---|---|---|
XBP1 | Homo sapiens (human) | 0.16 | |
DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 | |
Cyclin-T1 | Homo sapiens (human) | 0.013 | |
Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.0161 | |
Cyclin-dependent kinase 4 | Homo sapiens (human) | 0.216 | |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.026 | |
Cyclin-A2 | Homo sapiens (human) | 0.004 | |
G1/S-specific cyclin-D1 | Homo sapiens (human) | 0.216 | |
G1/S-specific cyclin-E1 | Homo sapiens (human) | 0.003 | |
Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.0041 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.8 | |
Cyclin-dependent kinase 7 | Homo sapiens (human) | 0.2 | |
Cyclin-dependent kinase 9 | Homo sapiens (human) | 0.013 | |
Cyclin-H | Homo sapiens (human) | 0.2 | |
CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | 0.2 | |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.01 | |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.01 | |
Serine/threonine-protein kinase SMG1 | Homo sapiens (human) | 0.11 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
1 other study(ies) available for azacrin and cgp 60474
Article | Year |
---|---|
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |